Co-Diagnostics (CODX)

Executive Summary

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. More Details


Trading at 47.9% below our estimate of its fair value

Earnings are forecast to grow 14.86% per year

Became profitable this year

Risk Analysis

Highly volatile share price over the past 3 months

High level of non-cash earnings

Shareholders have been substantially diluted in the past year

Snowflake Analysis

Flawless balance sheet and undervalued.

Similar Companies

Search for a company to compare.